IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice

Endocrinology

Volumn 155, Issue 1, 2014, Pages 143-155

  Quinn, LeBris S ^a,b   Anderson, Barbara G ^a,b   Conner, Jennifer D ^a   Wolden Hanson, Tami ^a   Marcell, Taylor J ^c  

^a Seattle Institute for Biomedical and Clinical Research   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; SIRTUIN 1;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENDURANCE TRAINING; GASTROCNEMIUS MUSCLE; INFANT; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RUNNING; SKELETAL MUSCLE; TREADMILL EXERCISE; UPREGULATION;

EID: 84891425912     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1645     Document Type: Article

References (45)

1. Benton CR, Wright DC, Bonen A. PGC-1-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab. 2008;33:843-862.
2. Matsakas A, Narkar VA. Endurance exercise mimetics in skeletal muscle. Curr Sports Med Rep. 2010;9:227-232.
3. Arnold AS, Egger A, Handschin C. PGC-1-And myokines in the aging muscle -A mini-review. Gerontology. 2011;57:37-43.
4. Perry CG, Lally J, Holloway GP, Heigenhauser GJ, Bonen A, Spriet LL. Repeated transientmRNAbursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol. 2010;588;4795-4810.
5. Dumke CL, Mark Davis J, Angela Murphy E, et al. Successive bouts of cycling stimulates genes associated with mitochondrial biogenesis. Eur J Appl Physiol. 2009;107:419-427.
6. Suwa M, Nakano H, Radak Z, Kumagai S. Endurance exercise increases the SIRT1 and peroxisome proliferator-Activated receptor coactivator-1-protein expressions in rat skeletal muscle. Metabolism. 2008;57:986-998.
7. Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the -chain of the interleukin-2 receptor. Science. 1994;264:965-968.
8. Quinn LS, Anderson BG, Conner JD, Wolden-Hanson T. IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPAR, SIRT1, PGC-1, and PGC-1-expression in male mice. Endocrinology. 2013;154:232-245.
9. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argilés JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol. 2009;296:E191-E202.
10. Quinn LS, Anderson BG, Conner JD, Pistilli EE, Wolden-Hanson T. Overexpression of IL-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle metabolism. Int J Interferon Cytokine Med Res. 2011; 3:29-42.
11. Nielsen AR, Hojman P, Erikstrup C, et al. Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab. 2008;93:4486-4493.
12. Barra NG, Reid S, MacKenzie R, et al. Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity. 2010;18:1601-1607.
13. Riechman SE, Balasekaran G, Roth SM, Ferrell RE. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol. 2004; 97:2214-2219.
14. Tamura Y, Watanabe K, Kantani T, Hyashi J, Ishida N, Kaneki M. Upregulation of circulating IL-15 by treadmill running in healthy individuals: Is IL-15 an endocrine mediator of the beneficial effects of endurance exercise Endocr J. 2011;58:211-215.
15. Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: A guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17:259-280.
16. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191:771-780.
17. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9:669-676.
18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101-1108.
19. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85.
20. Kleiner S, Nguyen-Tran V, Baré O, Huang X, Spiegelman B, Wu Z. PPAR-Agonism activates fatty acid oxidation via PGC-1-but does not increase mitochondrial gene expression and function. J Biol Chem. 2009;284:18624-18633.
21. Trimmer JK, Schwarz JM, Casazza GA, HorningMA,Rodriguez N, Brooks GA. Measurement of gluconeogenesis in exercising men by mass isotopomer distribution analysis. J Appl Physiol. 2002;93: 233-241.
22. McGillivray DG, Garland T Jr., Dlugosz EM, Chappell MA, Syme DA. Changes in efficiency and myosin expression in the small-muscle phenotype of mice selectively bred for high voluntary running activity. J Exp Biol. 2009;212:977-985.
23. Teunissen LP, Grabowski A, Kram R. Effects of independently altering body weight and body mass on the metabolic cost of running. J Exp Biol. 2007;210:4418-4427.
24. Arany Z, Lebrasseur N, Morris C, et al. The transcriptional coactivator PGC-1-drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 2007;5:35-46.
25. Williams CB, Gurd BJ. Skeletal muscle SIRT1 and the genetics of metabolic health: therapeutic activation by pharmaceuticals and exercise. Appl Clin Genet. 2012;5:81-91.
26. Philp A, Chen A, Lan DM, et al. Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-Activated receptor-α coactivator-1-(PGC-1-) deacetylation following endurance exercise. J BiolChem. 2011;286:30561-30570.
27. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
28. Schuler M, Ali F, Chambon C, et al. PGC1-expression is controlled in skeletal muscle by PPAR, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. 2006;4:407-414.
29. Okazaki M, Iwasaki Y, Nishiyama M, et al. PPAR+/-regulates the human SIRT1 gene transcription via Sp1. Endocr J. 2010;57:403-413.
30. Fuster G, Busquets S, Figueras M, et al. PPAR-mediates IL15 metabolic actions in myotubes: effects of hyperthermia. Int J Mol Med. 2009;24:63-68.
31. Wang YX, Zhang CL, Yu RT, et al. Regulation of muscle fiber type and running endurance by PPAR-. PLoS Biol. 2004;2:e294.
32. Nielsen AR, Mounier R, Plomgaard P, et al. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol. 2007;584:305-312.
33. Yeo NH, Woo J, Shin KO, Park JY, Kang S. The effects of different exercise intensity on myokine and angiogenesis factors. J SportsMed Phys Fitness. 2012;52:448-454.
34. Pedersen BK. The diseasome of physical inactivity-And the role of myokines in muscle-fat cross talk. J Physiol. 2009;587:5559-5568.
35. Quinn LS, Anderson BG. Interleukin-15, IL-15 receptor-α, and obe-sity: concordance of laboratory animal and human genetic studies. J Obes. 2011;2011:456347.
36. Quinn LS, Strait-Bodey L, Anderson BG, Argilés JM, Havel PJ. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int. 2005;29:449-457.
37. Pistilli EE, Bogdanovich S, Garton F, et al. Loss of IL-15R-Alters endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J Clin Invest. 2011;121:3120-3132.
38. Pistilli EE, Devaney JM, Gordish-Dressman H, et al. Interelukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine. 2008; 43:45-53.
39. Di Renzo L, Bigioni M, Bottini FG, Del Gobbo V, Premrov MG, Cianci R, De Lorenzo A. Normal weight obese syndrome: role of single nucleotide polymorphism of IL-15R-And MTHFR 6773T genes in the relationship between body composition and resting metabolic state. Eur Rev Med Pharmacol Sci. 2006;10:235-245.
40. Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, Argilés JM. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: Implications for treatment of skeletal muscle wasting disorders. Exp Cell Res. 2002;280:55-63.
41. Carbó N, López-Soriano J, Costelli P, et al. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer. 2000;83:526-531.
42. Bergamaschi C, Bear J, Rosati M, et al. Circulating IL-15 exists as heterodimeric complex with soluble IL-15R-in human and mouse serum. Blood. 2012;120:e1-e8.
43. Chertova E, Bergamaschi C, Chertov O, et al. Characterization and favorable in vivo properties of heterodimeric soluble IL-15-IL-15R-cytokine compared to IL-15 monomer. J Biol Chem. 2013;288: 18093-18103.
44. Marzetti E, Carter CS, Wohlgemuth SE, et al. Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Aging Dev. 2009;130:272-280.
45. Quinn LS, Anderson BG, Strait-Bodey L, Wolden-Hanson T. Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor expression. Exp Gerontol. 2010;45:106-112.